BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 25827699)

  • 1. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
    Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
    Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
    Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
    J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
    Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
    Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation.
    Komura M; Suzuki J; Adachi S; Takahashi A; Otomo K; Nitta J; Nishizaki M; Obayashi T; Nogami A; Satoh Y; Okishige K; Hachiya H; Hirao K; Isobe M
    Int Heart J; 2010 Jan; 51(1):34-40. PubMed ID: 20145349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
    Corrado D; Basso C; Nava A; Thiene G
    Cardiol Rev; 2001; 9(5):259-65. PubMed ID: 11520449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease.
    Kumar S; Baldinger SH; Kapur S; Romero J; Mehta NK; Mahida S; Fujii A; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):79-89. PubMed ID: 28940781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Kamath GS; Zareba W; Delaney J; Koneru JN; McKenna W; Gear K; Polonsky S; Sherrill D; Bluemke D; Marcus F; Steinberg JS
    Heart Rhythm; 2011 Feb; 8(2):256-62. PubMed ID: 20933608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Bauce B; Frigo G; Tarantini G; Napodano M; Turrini P; Ramondo A; Daliento L; Nava A; Buja G; Iliceto S; Thiene G
    Circulation; 2005 Jun; 111(23):3042-50. PubMed ID: 15939822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry).
    Christiansen MK; Haugaa KH; Svensson A; Gilljam T; Madsen T; Hansen J; Holst AG; Bundgaard H; Edvardsen T; Svendsen JH; Platonov PG; Jensen HK
    Am J Cardiol; 2020 Mar; 125(5):803-811. PubMed ID: 31924321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: an update.
    Calkins H; Marcus F
    Curr Cardiol Rep; 2008 Sep; 10(5):367-75. PubMed ID: 18715533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic arrhythmogenic right ventricular dysplasia/cardiomyopathy. A two-centre retrospective study of 15 symptomatic ARVD/C cases and focus on the diagnostic value of MRI in symptomatic ARVD/C patients.
    Dewilde W; Boersma L; Delanote J; Pollet P; Scholzel B; Wever E; Vandekerckhove Y
    Acta Cardiol; 2008 Apr; 63(2):181-9. PubMed ID: 18468198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.